Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol.

ABSTRACT:

Introduction

Accurate triage is an important first step to effectively manage the clinical treatment of severe cases in a pandemic outbreak. In the current COVID-19 global pandemic, there is a lack of reliable clinical tools to assist clinicians to perform accurate triage. Host response biomarkers have recently shown promise in risk stratification of disease progression; however, the role of these biomarkers in predicting disease progression in patients with COVID-19 is unknown. Here, we present a protocol outlining a prospective validation study to evaluate the biomarkers' performance in predicting clinical outcomes of patients with COVID-19.

Methods and analysis

This prospective validation study assesses patients infected with COVID-19, in whom blood samples are prospectiv

SUBMITTER: Tang B 

PROVIDER: S-EPMC7789210 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature